Form 8-K - Current report:
SEC Accession No. 0001193125-24-023367
Filing Date
2024-02-05
Accepted
2024-02-05 06:05:32
Documents
18
Period of Report
2024-02-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d620082d8k.htm   iXBRL 8-K 38910
2 EX-4.1 d620082dex41.htm EX-4.1 71267
3 EX-10.1 d620082dex101.htm EX-10.1 213083
4 EX-99.1 d620082dex991.htm EX-99.1 9430
8 GRAPHIC g620082g0203021142421.jpg GRAPHIC 2086
  Complete submission text file 0001193125-24-023367.txt   550830

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA tyra-20240201.xsd EX-101.SCH 2828
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE tyra-20240201_lab.xml EX-101.LAB 17977
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tyra-20240201_pre.xml EX-101.PRE 11243
19 EXTRACTED XBRL INSTANCE DOCUMENT d620082d8k_htm.xml XML 3629
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

EIN.: 831476348 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40800 | Film No.: 24593821
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)